首页> 外文期刊>Journal of experimental & clinical cancer research : >Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients
【24h】

Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients

机译:遗传性非息肉性结直肠癌患者与零星结直肠癌患者的生存率

获取原文
           

摘要

Background Patients with hereditary non-poliposys colorectal cancer (HNPCC) have better prognosis than sporadic colorectal cancer (CRC). Aim of our retrospective study was to compare the overall survival between sporadic CRC and HNPCC patients. Methods We analyzed a cohort of 40 (25 males and 15 females) HNPCC cases with a hospital consecutive series of 573 (312 males and 261 females) sporadic CRC observed during the period 1970–1993. In 15 HNPCC patients we performed mutational analysis for microsatellite instability. Survival rates were calculated by Kaplan-Meier method and compared with log rank test. Results The median age at diagnosis of the primary CRC was 46.8 years in the HNPCC series versus 61 years in sporadic CRC group. In HNPCC group 85% had a right cancer location, vs. 57% in the sporadic cancer group. In the sporadic cancer group 61.6% were early-stages cancer (Dukes' A and B) vs. 70% in the HNPCC group (p = ns). The crude 5-years cumulative survival after the primary CRC was 94.2% in HNPCC patients vs. 75.3% in sporadic cancer patients (p Conclusion Our results show that overall survival of colorectal cancer in patients with HNPCC is better than sporadic CRC patients. The different outcome probably relates to the specific tumorigenesis involving DNA mismatch repair dysfunction.
机译:背景遗传性非淋巴结性大肠癌(HNPCC)患者的预后要好于散发性大肠癌(CRC)。这项回顾性研究的目的是比较散发性CRC和HNPCC患者之间的总体生存率。方法我们分析了1970-1993年间连续入院的573例(312例男性和261例女性)散发性CRC的40例HNPCC病例(男性25例,女性15例)。在15名HNPCC患者中,我们进行了微卫星不稳定性的突变分析。生存率采用Kaplan-Meier方法计算,并与对数秩检验进行比较。结果HNPCC系列诊断为原发性CRC的中位年龄为46.8岁,而散发性CRC组为61岁。在HNPCC组中,有85%的癌症位置正确,而在散发性癌症组中,这一比例为57%。在散发性癌症组中,早期癌症(Dukes'A和B)为61.6%,而在HNPCC组中为70%(p = ns)。 HNPCC患者原发性CRC后5年的粗略累积存活率为94.2%,而散发性癌症患者为75.3%(p结论)我们的结果表明,HNPCC患者的结直肠癌总体存活率比散发性CRC患者更好。结果可能与涉及DNA错配修复功能障碍的特定肿瘤发生有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号